Email
Mot de passe
Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Ou connectez-vous avec votre réseau social favori

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

MATERIOMICS

MATERIOMICS_logo
6
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

MATERIOMICS makes pharma, drug development and toxicology faster, more reliable and more successful -replacing animal tests- with the revolutionary family of ACE organ tests models (liver, colon, heart) featuring our proprietary surface topographies

Maastricht, Maastricht, Netherlands

Send a message

Anglais

MATERIOMICS Who are we?

MATERIOMICS is a VC backed biotech company located in The Netherlands. Surface structure, next to chemical composition, directs the interaction between (medical) devices and (human) cells. Based on this concept -cell behavior is guided by surface structure- MATERIOMICS designs algorithm-based unique surface topographies to improve the performance of cell culture ware and medical devices.

Using our proprietary TopoChip technology we identify the optimal designed surface topography to...

See more

MATERIOMICS is a VC backed biotech company located in The Netherlands. Surface structure, next to chemical composition, directs the interaction between (medical) devices and (human) cells. Based on this concept -cell behavior is guided by surface structure- MATERIOMICS designs algorithm-based unique surface topographies to improve the performance of cell culture ware and medical devices.

Using our proprietary TopoChip technology we identify the optimal designed surface topography to functionalize cell culture ware and improve the condition, quality and quantity of cells cultured in vitro (in the lab). The revolutionary family of ACE products significantly enhance organ test model performance and make pharma, drug development and toxicology faster, more reliable and more successful.

Our first ACE product is ACE/liver. The current gold standard allows human liver cells to be cultured for max. 8 days while loosing their typical behavior and functionality,  requires complex coating conditions and is very limited in its use. In strong contrast, ACE/liver allows these cells to grow for a month, while remaining their typical behavior and functionality, and no coatings are needed. ACE products are in line with end-user pipelines as well as manufacturing processes.

Next to ACE, MATERIOMICS designs topographies to substantially augment medical implants including breast implants, catheters, orthopedic implants and biosensors. For every application MATERIOMICS has the best surface.

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

Seal of Excellence
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not received funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
781 Entities

Communities

Our history

Start in 2009

  • 2009

    Founded by Prof. Clemens van Blitterswijk, Prof. Jan de Boer and Frank-Jan van der Velden, MBA.

  • 2011

    Co-owner and co-inventor Dr. Ir. Bernke Papenburg started working full-time for MATERIOMICS.

  • 2011

    1. Secured NGI pre-seed grant of €250k to progress the business case. 2. First commercial project.

  • 2015

    Secured VC Seed round of €1.4 million

  • 2016-2017

    1. EU-SME phase 1 grant: ACE business case development 2. Alira Health Wound Care Innovation Award

to be continued ...